Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCP) Liabilities and Shareholders Equity (2016 - 2025)

Chs' Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $18.9 billion for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 0.79% year-over-year to $18.9 billion; the TTM value through Nov 2025 reached $38.6 billion, up 1.77%, while the annual FY2025 figure was $18.9 billion, 0.79% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $18.9 billion at Chs, down from $19.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $21.1 billion in Q4 2022 and bottomed at $17.6 billion in Q3 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $19.2 billion (2024), against an average of $19.4 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 11.75% in 2022 before it decreased 7.31% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $19.6 billion in 2021, then grew by 7.43% to $21.1 billion in 2022, then dropped by 10.04% to $19.0 billion in 2023, then fell by 1.28% to $18.7 billion in 2024, then grew by 0.79% to $18.9 billion in 2025.
  • Per Business Quant, the three most recent readings for CHSCP's Liabilities and Shareholders Equity are $18.9 billion (Q3 2025), $19.7 billion (Q2 2025), and $18.7 billion (Q3 2024).